Preclinical evaluation of psoralen inactivation as a platform for developing a killed, whole cell vaccine for Enterotoxigenic E. coli (ETEC)
补骨脂素灭活作为开发产肠毒素大肠杆菌 (ETEC) 灭活全细胞疫苗的平台的临床前评估
基本信息
- 批准号:10042258
- 负责人:
- 金额:$ 7.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acute DiarrheaAddressAdultAdverse effectsAntibiotic ResistanceAntibodiesAntibody ResponseAntigen PresentationAntigensAreaBacteriaBacterial Antibiotic ResistanceBacterial InfectionsBacterial VaccinesBiological AssayCampylobacter jejuniCellsCessation of lifeChemicalsChildChronicCollaborationsComplementDataDefectDengue VaccineDevelopmentDiseaseEngineeringEnteralEnterobacteriaceaeEpitopesEscherichia coli VaccinesEtiologyFormalinGastrointestinal DiseasesGenomeGoalsHealthcareHospitalsImmune TargetingImmune responseImmune systemImmunityImmunologicsIn VitroIndividualInfectionInfection preventionKnowledgeLinkMeasuresMedical ResearchMembrane ProteinsMethodsMilitary PersonnelModelingMorbidity - disease rateMusNucleic AcidsOrganismPatient CarePharmaceutical PreparationsPreventionProtein ConformationProteinsPseudomonas aeruginosaPsoralensPublic HealthPyrimidineSafetySerumShigellaShigella flexneriShigella sonneiSurfaceSyndromeTestingTimeUltraviolet A radiationUltraviolet RaysVaccinationVaccinesVirulenceVulnerable PopulationsWhole Cell VaccineWorkacute infectionclinical translationcomparativecrosslinkdiarrheal diseaseenterotoxigenic Escherichia coliexperienceexperimental studygastrointestinalgenetic manipulationimmune functionimmunogenicimmunogenicityimprovedin vitro Assayin vivoirradiationmortalitymouse modelnovel strategiespathogenpathogenic bacteriapre-clinicalpreclinical evaluationpreclinical studypreservationpreventprotein crosslinkresistant strain
项目摘要
Westcott.Project Summary/Abstract
Enterotoxigenic E. coli (ETEC), Shigella flexneri and Campylobacter jejuni are the predominant bacterial
causes of morbidity and mortality from gastrointestinal (GI) disease in the developing world. Episodes of acute
diarrhea caused by these agents have been linked to developmental defects and chronic GI syndromes.
Vaccines that are safe for use in young children as well as adult travelers and deployed military are needed to
prevent infection and post-infection sequellae caused by these organisms. Formalin inactivation is the current
standard for generating killed, whole cell bacterial vaccines. This approach does not require genetic
manipulations or extensive knowledge of antigens that induce protective immune responses. However,
formalin crosslinks proteins, which has the potential to destroy antigenic epitopes that induce protective
immune responses in the context of live bacterial infection. We propose to test the feasibility of an alternative
inactivation method to generate safe, whole cell vaccines for enteric bacteria. Psoralen is a photoactivatable
drug that reversibly intercalates into nucleic acids. Following irradiation with long wavelength UV light
(P+UVA), covalent inter-strand crosslinks form at pyrimidine residues, preventing genome replication. Since
P+UVA inactivates bacteria by crosslinking nucleic acids rather than proteins, we hypothesize that protein
antigens will be preserved in a native form, generating vaccines with superior immunogenicity. We have
successfully inactivated ETEC using P+UVA. With this proposal we will extend the ETEC work by comparing
P+UVA to formalin-inactivated ETEC with respect to antigen preservation and immunogenicity using
established in vitro assays and murine models. A direct comparative analysis of the 2 inactivation methods is
needed to assess the value and feasibility of the P+UVA approach as an agile platform for enteric bacterial
vaccines, and more generally for vaccines to prevent antibiotic-resistant bacterial infections that impact patient
care in hospital settings.
.
1
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin.
- DOI:10.3390/microorganisms11082040
- 发表时间:2023-08-09
- 期刊:
- 影响因子:4.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marlena Moors Westcott其他文献
Marlena Moors Westcott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Molecular Pathogenesis of enterotoxigenic E. coli associated enteropathy
产肠毒素大肠杆菌相关性肠病的分子发病机制
- 批准号:
10656056 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Identification of the antigenic targets of the clonal antibody response to Clostridioides difficile infection
鉴定针对艰难梭菌感染的克隆抗体反应的抗原靶点
- 批准号:
10742376 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Actionable categories of avoidable hospital care among adults with cancer
成人癌症患者可避免住院治疗的可行类别
- 批准号:
10714125 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Undernutrition, microbiota maturation, and adaptive immunity in Bangladeshi children
孟加拉国儿童的营养不良、微生物群成熟和适应性免疫
- 批准号:
10718949 - 财政年份:2023
- 资助金额:
$ 7.75万 - 项目类别:
Deciphering the pathogenesis of an enteric pathogen in neonatal and immunodeficient mice
破译新生小鼠和免疫缺陷小鼠肠道病原体的发病机制
- 批准号:
10370045 - 财政年份:2022
- 资助金额:
$ 7.75万 - 项目类别: